BioSpace News Archive

Biotech Beach

Engrail Therapeutics Extends Series A Financing to $64 Million

Engrail Therapeutics™ today announced the close of a $32 million extension of its Series A financing round, which brings the total round to $64 million.

August 3, 2021
·
3 min read
Deals

Infinity Pharmaceuticals Reports Inducement Grants to Chief Scientific Officer under Nasdaq Listing Rule 5635(c)(4)

Infinity Pharmaceuticals, Inc. today announced the grant of an inducement stock option award and an inducement restricted stock unit award to Stephane Peluso, Ph.D.

August 3, 2021
·
3 min read
Genetown

Stoke Therapeutics to Present at Upcoming Investor Conferences in August 2021

Stoke Therapeutics, Inc., a biotechnology company dedicated to addressing the underlying cause of severe diseases by up-regulating protein expression with RNA-based medicines, announced that Chief Executive Officer Edward M. Kaye, M.D., will present at two upcoming investor conferences in August.

August 3, 2021
·
2 min read
FDA

FDA Grants Breakthrough Device Designation Status for Hancock Jaffe’s VenoValve

Hancock Jaffe Laboratories today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation status to the VenoValve®

August 3, 2021
·
5 min read
Genetown

Albireo to Present at the 2021 Wedbush PacGrow Virtual Healthcare Conference

Albireo Pharma, Inc. today announced that Ron Cooper, President and Chief Executive Officer and Simon Harford, Chief Financial Officer, will present at the 2021 Wedbush PacGrow Virtual Healthcare Conference on Tuesday, August 10, at 3:30 p.m. ET.

August 3, 2021
·
1 min read
Genetown

Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

Foghorn Therapeutics Inc. today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11.

August 3, 2021
·
1 min read
Business

Hemanext Announces Appointment Of Paul M. Ness, M.D., To Board Of Directors

Hemanext Inc today announced the appointment of Paul M. Ness, M.D., to its Board of Directors.

August 3, 2021
·
6 min read
Genetown

Iterative Scopes Raises $30 Million Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology

Iterative Scopes today disclosed that it has closed a $30 million Series A financing.

August 3, 2021
·
6 min read
Biotech Bay

Pear Therapeutics to Participate in Upcoming Investor Conferences - Aug 03, 2021

Pear Therapeutics, Inc. announced management’s participation in the following virtual investor conferences in August 2021

August 3, 2021
·
1 min read
Business

WuXi STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland

WuXi STA – a subsidiary of WuXi AppTec – today announced that it has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland from Bristol Myers Squibb.

August 3, 2021
·
2 min read